First-In-Human Clinical Experience with CER-1236, a First-In-Class TIM-4–Based Phagocytic CAR-T Therapy, Including Platelet Transfusion Independence In an Index Patient with High-Risk MDS/AML (inv(3)/Mecom)

CER-1236 - CERo Therap

https://tandem.virtual-meeting.org/programme/presentation/681339

Michael Maris; Luke Mountjoy; Robert Sikorski; Brandon Cieniewicz; Kristen Pierce; Hongxiu Ning; Elizabeth Padilla; Neil Sankar; Stephen Strickland; Abhishek Maiti

Jan 28, 2026